1. Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial. Issue 5 (May 2015) Authors: Ramsauer, Katrin; Schwameis, Michael; Firbas, Christa; Müllner, Matthias; Putnak, Robert J; Thomas, Stephen J; Desprès, Philippe; Tauber, Erich; Jilma, Bernd; Tangy, Frederic Journal: Lancet infectious diseases Issue: Volume 15:Issue 5(2015:May) Page Start: 519 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial. Issue 5 (May 2015) Authors: Ramsauer, Katrin; Schwameis, Michael; Firbas, Christa; Müllner, Matthias; Putnak, Robert J; Thomas, Stephen J; Desprès, Philippe; Tauber, Erich; Jilma, Bernd; Tangy, Frederic Journal: Lancet infectious diseases Issue: Volume 15:Issue 5(2015:May) Page Start: 519 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Respiratory Syncytial Virus NS1 Protein Targets the Transactivator Binding Domain of MED25. Issue 19 (15th October 2022) Authors: Dong, Jiawei; Basse, Vincent; Bierre, Maxime; Peres de Oliveira, Andressa; Vidalain, Pierre-Olivier; Sibille, Pierre; Tangy, Frederic; Galloux, Marie; Eleouet, Jean-Francois; Sizun, Christina; Bajorek, Monika Journal: Journal of molecular biology Issue: Volume 434:Issue 19(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗